The chemical reprogramming of unipotent adult germ cells towards authentic pluripotency and de novo establishment of imprinting

Yuhan Chen , Jiansen Lu , Yanwen Xu , Yaping Huang , Dazhuang Wang , Peiling Liang , Shaofang Ren , Xuesong Hu , Yewen Qin , Wei Ke , Ralf Jauch , Andrew Paul Hutchins , Mei Wang , Fuchou Tang , Xiao-Yang Zhao

Protein Cell ›› 2023, Vol. 14 ›› Issue (7) : 477 -496.

PDF (12777KB)
Protein Cell ›› 2023, Vol. 14 ›› Issue (7) :477 -496. DOI: 10.1093/procel/pwac044
Research Articles
The chemical reprogramming of unipotent adult germ cells towards authentic pluripotency and de novo establishment of imprinting
Author information +
History +
PDF (12777KB)

Abstract

Although somatic cells can be reprogrammed to pluripotent stem cells (PSCs) with pure chemicals, authentic pluripotency of chemically induced pluripotent stem cells (CiPSCs) has never been achieved through tetraploid complementation assay. Spontaneous reprogramming of spermatogonial stem cells (SSCs) was another non-transgenic way to obtain PSCs, but this process lacks mechanistic explanation. Here, we reconstructed the trajectory of mouse SSC reprogramming and developed a five-chemical combination, boosting the reprogramming efficiency by nearly 80- to 100-folds. More importantly, chemical induced germline-derived PSCs (5C-gPSCs), but not gPSCs and chemical induced pluripotent stem cells, had authentic pluripotency, as determined by tetraploid complementation. Mechanistically, SSCs traversed through an inverted pathway of in vivo germ cell development, exhibiting the expression signatures and DNA methylation dynamics from spermatogonia to primordial germ cells and further to epiblasts. Besides, SSC-specific imprinting control regions switched from biallelic methylated states to monoallelic methylated states by imprinting demethylation and then re-methylation on one of the two alleles in 5C-gPSCs, which was apparently distinct with the imprinting reprogramming in vivo as DNA methylation simultaneously occurred on both alleles. Our work sheds light on the unique regulatory network underpinning SSC reprogramming, providing insights to understand generic mechanisms for cell-fate decision and epigenetic-related disorders in regenerative medicine.

Graphical abstract

Keywords

reprogramming / spermatogonial stem cell / tetraploid complementation / imprinting

Cite this article

Download citation ▾
Yuhan Chen, Jiansen Lu, Yanwen Xu, Yaping Huang, Dazhuang Wang, Peiling Liang, Shaofang Ren, Xuesong Hu, Yewen Qin, Wei Ke, Ralf Jauch, Andrew Paul Hutchins, Mei Wang, Fuchou Tang, Xiao-Yang Zhao. The chemical reprogramming of unipotent adult germ cells towards authentic pluripotency and de novo establishment of imprinting. Protein Cell, 2023, 14 (7) : 477-496 DOI:10.1093/procel/pwac044

登录浏览全文

4963

注册一个新账户 忘记密码

Introduction

Reprogramming describes the process of reverting the cell fate of differentiated cells to a pluripotent state and provides therapeutic potential for regenerative medicine. For the last half-century, great success had been achieved by the development of somatic cell reprogramming by nuclear transfer (Gurdon and Byrne, 2003; Byrne et al., 2007), transcription factors overexpression (Takahashi and Yamanaka, 2006; Takahashi et al., 2007), or chemical induction (Hou et al., 2013; Zhao et al., 2015) of pluripotency. However, although many regulatory networks and biological processes have been investigated in reprogramming, and many novel methods have been developed based on these insights, incomplete and defective patterns of epigenetic reprogramming remain a common occurrence in reprogramming (Li et al., 2010; Samavarchi-Tehrani et al., 2010; Takikawa et al., 2013; Zhao et al., 2015, 2018; Matoba et al., 2018; Yagi et al., 2019). This suggests there are several unknown mechanisms that remain to be characterized. Amongst the many reprogramming strategies, CiPSCs was a breakthrough, as it avoided the use of oocytes or genetic manipulation, making cell fate transitions potentially easier to control in a cost-effective and nonimmunogenic way (Hou et al., 2013). However, tetraploid complementation, the gold standard test for pluripotency and developmental potency, had been confirmed in embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) but not in CiPSCs (Zhao et al., 2009). This hints at functional deficiencies, likely epigenetic, in CiPSCs that compromises their full pluripotency capability.

Spermatogonial stem cells (SSCs) locate in the testis and initiate continuous spermatogenesis, these SSCs can be well maintained in vitro for several passages (Kanatsu-Shinohara et al., 2003). Intriguingly, in culture, a tiny majority of SSCs spontaneously convert to germline-derived pluripotent stem cells (gPSCs), in a form of non-transgenic reprogramming (Kanatsu-Shinohara et al., 2004; Guan et al., 2006; Ko et al., 2009). Interestingly, the spontaneous way of SSCs reprogramming is quite different from other cell fate transitions triggered by extra induction, suggesting distinct regulatory mechanisms in this biological process. However, the extremely low efficiency (about 0.05%) of spontaneous SSC reprogramming hinders the investigation of this unique phenomenon and the underlying mechanisms (An et al., 2017; Jeong et al., 2017), thus an efficient SSC to gPSC reprogramming system is urgently required. More importantly, the fully pluripotency of gPSCs had not been verified by the most stringent test for pluripotency, which stimulated us to improve the developmental potency of gPSCs.

In this study, we established a highly efficient (4.2%) SSC reprogramming system that can generate gPSCs via chemical induction. These gPSCs can form a complete mouse in tetraploid complementation assays, confirming their true pluripotency. Further, we showed that SSC reprogramming traversed through an inverted route of in vivo germ cell development and the chemical-induced gPSCs had correct imprinting status using single-cell multi-omics (transcriptome and DNA methylome) analysis. Our work shows the sophisticated regulatory network in cell fate transitions and the critical importance of the accurate re-establishment of imprinted pattern during reprogramming.

Results

Reconstruction of SSC reprogramming roadmap by single-cell RNA sequencing

Functional SSCs were established from postnatal day (PND) 5.5 Oct4-EGFP mice (also known as OG2, expression of EGFP is under the control of Oct4 promoter) (Szabó et al., 2002), feature genes expression (GFRa1, ZBTB16, DDX4, and OCT4) and spermatogenesis potency of SSCs were carefully investigated (Fig. S1A and S1B). Spontaneous SSC-reprogramming efficiency has been reported to vary across laboratories, hence we adopted a relatively efficient and reproducible system created by Ko et al. (2009). After 16–20 days of cultivation without passaging, Oct4-EGFP positive (OG(+)) colonies with typical ESC morphology appeared amongst the SSC colonies. gPSCs were then established by transferring the ESC-like colonies to ground state ESC culture medium (2iL) (Ying et al., 2008). Thus, reprogramming in SSC medium and ESC medium were designated as the early and late stage of SSC reprogramming, respectively (Fig. 1A and 1B). We confirmed that key pluripotent markers (OCT4, NANOG, and SSEA1) were activated, and the germ cell marker DDX4 was silenced in gPSCs (Fig. S1C). Chromosome integrity and differentiation potential of gPSCs were examined by karyotype- and teratoma formation assays, respectively (Fig. S1D and S1E). Furthermore, developmental potency was corroborated by both germline transmission and chimera formation (Fig. S1F–I). We confirmed that gPSCs derived from mouse SSCs possessed pluripotency comparable to ESCs.

To decipher the sophisticated regulatory networks during SSC reprogramming, 4,464 individual cells from two batches of SSC reprogramming at ten different time points (from day 0 to day 27), together with gPSCs, ESCs were collected for scRNA-seq analysis (modified STRT-seq) (Figs. 1C, S1J and S1K; Table S1) (Dong et al., 2018). On average, 8348 expressed genes and 267,298 UMIs (unique molecular identifiers) were detected in each cell after quality control (Fig. S1L). We first performed UMAP (uniform manifold approximation and projection) and graph-based clustering on single cells in the SSC medium, and 18 clusters were detected (Figs. 1D, S1K and S1M). Expression of well-defined marker genes was used to identify the cell type or cell type bias within each cluster, including SSC-specific genes (Zbtb16, Dazl, and Dmrt1) (Schrans-Stassen et al., 2001; Costoya et al., 2004; Zhang et al., 2016), pluripotent genes (Oct4, Nanog, and Sox2) (Zhou et al., 2016), fibroblast specific genes (Col12a1, Col5a2, and Ccn2) (Schiebinger et al., 2019), meiosis-related genes (Spo11 and Dpep3) (Romanienko and Camerini-Otero, 2000; Xie et al., 2019), early-pluripotent genes (Esrrb, Dppa2, and low level of Oct4) (Zhao et al., 2018), and neuro-related genes (Nr2f1, Foxp2, Pitx2, and Msx1) (Schiebinger et al., 2019). Based on these genes, we designated the 18 clusters as SSC1-4, reprogramming 1-4 (RPG1-4), fibroblast 1-2, early-pluripotent 1-2, meiotic 1-2, and neural 1-4 (Figs. 1D and S1N).

We next used RNA velocity, Monocole2, and partition-based graph abstraction (PAGA) analysis, to reconstruct the developmental trajectories (Figs. 1E, 1F, and S2A–C) (Trapnell et al., 2014; La Manno et al., 2018; Wolf et al., 2019). Briefly, a subset of SSCs acquired fibroblast identity (clusters 9 and 10); from day 10 to day 20, early-pluripotent features were gained in a group of SSCs (clusters 11 and 12); simultaneously, SSCs with neural characteristics appeared from day 12 to day 27 (clusters 15 to 18); some other SSCs could transiently express meiosis related genes from day 14 to day 16 (clusters 13 and 14); notably, a group of cells diminished SSC signatures and obtained pluripotent characters from day 14 to day 23 (clusters 5 to 8) (Figs. 1F and S2D).

Hallmarks of the roadmap of SSC reprogramming

Among these cell-fate transition trajectories, we designated the route with pluripotent signatures (SSC1-4 and RPG1-4) as the successful reprogramming branch, whilst all other routes were classified as failed branches (Figs. 1G and S2E). Gene ontology (GO) analysis was performed on the differentially expressed genes (DEGs) in either successful- or failed reprogramming branches, respectively. ‘Embryo development’, ‘pluripotent stem cell’ as well as ‘chromatin modification’ related GO terms were enriched in the successful reprogramming branch; meanwhile, ‘extracellular matrix organization’, ‘meiotic division’ and ‘neural differentiation’ related events were occurred in the failed reprogramming branches (Figs. 1H and S2F; Table S2).

Intriguingly, glycolysis-metabolism-related terms (‘glycolysis/gluconeogenesis’) were enriched in the successful branch, and glycolysis related genes (including Hif1a, Epas1 (Hif2a), Slc2a1, Ldha) were upregulated from SSC1 to RPG4, suggesting the activation of glycolysis during SSC reprogramming (Fig. 1H and 1I). Indeed, lactic acid was elevated after day 16 (Fig. 1J), and addition of 2-deoxy-d-glucose (2-DG, a glycolysis inhibitor) (Kanatsu-Shinohara et al., 2016), suppressed the emergence of gPSCs as measured by OG(+) colonies (Fig. 1K); importantly, glycolysis activation was mainly observed in the successful branch but not in the failed branches (Fig. S2G), implying a vital correlation between glycolysis and successful reprogramming. Recent studies have identified an intimate link between metabolic processes and epigenetic control, as many metabolic processes provide and control reaction substrates for epigenetic modifications in cell fate transitions (Ly et al., 2020; Tarazona and Pourquie, 2020). In our study, epigenetic regulation related GO terms (‘methylation’) and genes (Dnmt3b, Dnmt3l, Tet1, Tet2) were enriched in the successful branch of SSC reprogramming (Fig. 1H and 1L; Table S2). Moreover, the expression of both glycolysis- and DNA methylation-related genes was positively correlated with the pluripotent features from RPG1 to RPG4, suggesting the direct or indirect regulation of glycolytic-metabolism and DNA methylation/demethylation in SSC reprogramming (Fig. S2H; Table S2).

This comprehensive roadmap of SSC reprogramming to gPSCs will allow us to explore the unique and common events between SSC reprogramming and other reprogramming processes, including CiPSC and iPSC (Fig. 1M, see Methods) (Zhao et al., 2018; Schiebinger et al., 2019). Though few genes simultaneously activated or silenced among these three reprogramming processes, ‘epithelial cell proliferation’ and ‘pluripotency network’ were identified as the common events in all three reprogramming processes. Of note, the enrichment of glycolysis-related genes in the first stage of SSC reprogramming was apparently distinct with the relatively activation of ‘oxidative phosphorylation’ and ‘TCA cycle’ in MEF reprogramming (Figs. 1N and S2I; Table S3). Particularly, the downregulation of ‘spermatogenesis’- and ‘DNA methylation involved in gamete generation’-related genes were only observed in SSC reprogramming, which was due to the different origin of initial cells (Fig. S2J; Table S3).

A high-efficient SSC reprogramming system developed by a five-chemicals combination

In order to improve the SSC reprogramming system, we carried out small-molecule screening by adding 185 candidate small molecules chosen according to our single cell analysis as well as previous studies (Table S4) (Takashima et al., 2013). Interestingly, SGC707 (a PRMT3 inhibitor), vitamin C (a DNA demethylation related chemical), (–)-Epigallocatechin Gallate (EGCG, a natural product regulating DNA methyltransferase), Daphnetin (a natural coumarin derivatives inhibiting protein kinase), PTFα1 (a p53 inhibitor), and tauroursodeoxycholic acid (TUDCA, an anti-apoptosis chemical) were identified to significantly improve the efficiency of SSC reprogramming, respectively (Fig. 2A and 2B) (Takashima et al., 2013). To preserve the genomic integrity of gPSCs, PTFα1 was excluded in the subsequent studies. We then asked if the combination of all these five chemicals, SGC707, vitamin C, EGCG, Daphnetin, and TUDCA (named 5C hereafter) could synergistically improve the efficiency of SSC reprogramming. Notably, in the early stage of reprogramming, approximately 80–100 times more OG(+) colonies as well as significant elevation of lactic acid were observed in 5C treatment than in the control (Fig. 2C–F). Of note, 5C treatment not only significantly improved reprogramming efficiency, but also accelerated the reprogramming progress, as OG(+) and ESC-like colonies could be detected as early as day 10 (Fig. 2E). Moreover, the number of gPSC colonies with 5C treatment was nearly 1000 times more than the control after replating to ESC medium in the late stage of reprogramming (Fig. 2C and 2G).

We next evaluated if each chemical in 5C cocktail was necessary or sufficient for the high efficiency of gPSC reprogramming, by withdrawal experiments. The results indicated that all those chemicals contributed to increasing the efficiency of reprogramming, and vitamin C was a dominant one but it could not substitute the other four chemicals in 5C (Fig. 2H and 2B). Finally, we confirmed the pluripotency of gPSCs derived from 5C treatment (5C-gPSCs) by marker genes expression, teratoma formation, germline transmission, and chimera formation (Fig. 2I–N). Thus, 5C-gPSCs are functionally comparable to ESCs.

5C-gPSCs displayed superior developmental potency and less growth deficiency than gPSCs, as determined by tetraploid complementation

Besides the efficiency improvement, we also wondered whether the chemical treatment was beneficial to the developmental potency of gPSCs. To this end we performed tetraploid complementation assay (‘gPSC 4N-comp’). When Oct4-EGFP PSCs were injected into tetraploid ICR blastocysts, normal E12.5 fetus and live pups could be developed from 5C-gPSCs, gPSCs, and ESCs (Figs. 3A, S3A, and S3B; Table 1). Simple sequence length polymorphism (SSLP) and transgenic analyses followed by PCR confirmed the lineage of the tetraploid complementation mice (Fig. 3B and 3C; Table S4). Additionally, all of the Oct4-EGFP 4N-comp mice were black B6D2F1 males; when mated with white ICR females, gPSC, 5C-gPSC and ESC 4N-comp mice could produce OG(+) blastocysts with normal morphology and offspring with a uniform brown coat color (Figs. 3D, 3E, and S3C–E). Collectively, these data demonstrated the developmental pluripotency of 5C-gPSCs and gPSCs to produce 4N-comp mice.

Though gPSCs and 5C-gPSCs could both support intact embryo development of 4N-comp mice, the chance to get viable offspring from gPSCs was lower than that of 5C-gPSCs (0% and 3.8% vs. 4.9% and 6.1%; Fig. 3F, Table 1). Furthermore, 4N-comp mice derived from gPSCs showed heavier neonatal body weight, much lower survival rate and growth curve than that from 5C-gPSCs and ESCs (Fig. 3G–I; Table 1). These deficiencies suggested that gPSC 4N-comp mice harbored some epigenetic disorders, as previously reported (Choi et al., 2017; Li et al., 2017; Yagi et al., 2017). DNA methylation analysis by bisulfite-sequencing demonstrated that the proper methylation level of whole genome and total imprinting control regions (ICRs) were observed in ESCs and 5C-gPSCs, but not in gPSCs (Figs. 3J and S3F). Specifically, the paternal imprinting reprogrammed from SSCs to both gPSCs and 5C-gPSCs (Fig. 3K). Previously, it had been verified the closely correlation between the silencing of paternal imprinted Dlk1-Dio3 region (DD region) as well as miRNAs in this cluster and the developmental potency of iPSCs (Liu et al., 2010; Stadtfeld et al., 2010). In our study, the DNA methylation of DD region and miRNAs encoded locus in this cluster preserved a relatively moderate level in ESCs and 5C-gPSCs; however, significant hypomethylation of DD regions and miRNA locus were observed in gPSCs (Fig. 3L and 3M). Besides, the methylation status of maternal imprinting control regions (ICRs) was partially reset in 5C-gPSCs, but not in gPSCs, meanwhile, specific maternal imprinted genes overexpression (Igf2r, Kcnq1ot1, Peg3, and Snrpn) were observed in gPSCs (Figs. 3N, 3O, and 7E). Together, these data suggested a positive-correlation between proper imprinting status of 5C-gPSCs and their subsequent developmental and growth advantages in tetraploid-derived mice.

SSCs were reprogrammed to a pluripotent state along a reversed germline differentiation trajectory

To further decode the regulatory mechanism by which gPSCs achieved reprogramming, scRNA-seq was performed throughout the SSC reprogramming process induced by 5C and under control conditions (Fig. S4A–C; Table S1). Previously, the enrichment of GO terms related to ‘reproductive system development’ and ‘gastrulation’ in the successful branch suggested a correlation between SSC reprogramming and embryonic germ cell development (Fig. 1H). Thus, to integrate the analysis we included data from mouse male germ cells and somatic cells in the genital ridge or testis from embryonic day (E) 6.5 to postnatal day (PND) 5.5 (Zhao et al., 2021). Intriguingly, single cells from the successful reprogramming branch fitted much better with the in vivo germ cells, compared to gonadal somatic cells and embryonic stem cells after data integration (Figs. 4A, S4D, and S4E). In depth analysis suggested that regardless of the SSC reprogramming conditions, SSC1/2/3/4 resembled undifferentiated- and differentiating spermatogonia, and a subpopulation of RPG1 shared features with mitotic arrest primordial germ cell (mitotic arrest PGC); signatures of RPG2 were comparable to mitotic- and migrating PGC, and RPG3/4 acquired representative characteristics of the epiblasts (Figs. 4B and S4F) (Kiselev et al., 2018).

Furthermore, the upregulation of 836 genes out of 1425 stage-specific DEGs of in vivo germ cell development were captured in the corresponding clusters during SSC reprogramming, reflecting the acquisition of fetal germ cell (FGC) features and the loss of spermatogenesis signatures in this reprogramming process (Fig. 4C; Table S5). For instance, pluripotent markers L1td1, Rhox5, Sox2, and Nanog first expressed in RPG1; PGC marker genes Prdm14, Dppa3, Bmp4, and Tfap2c were predominantly expressed in RPG2; epiblast-related markers Eomes, Otx2, Fgf5, and Fgf15 were exclusively expressed in RPG3/4 (Figs. 4D and S4G). Immunostaining verified the expression patterns of these germ cell markers (RHOX5, L1TD1, PRDM14, TFAP2C, DPPA3, and OTX2) during SSC reprogramming (Figs. 4E–G and S4H). In addition, the expression of RPG2 specific marker (PRDM14) and RPG3/4 marker (OTX2) in OG(+) colonies during reprogramming also displayed mutually exclusive dynamics as determined by in situ immunostaining. The proportion of PRDM14(+)OTX2(–) colonies in OG(+) colonies declines from 93% on day 10 to 7% and 0% on day 13 and day 16, respectively; while the proportion of PRDM14(–)OTX2(+) colonies in OG(+) colonies increased from 0% on day 10 to 7% and 90% on day 13 and day 16, respectively; and the proportion peak of PRDM14(+)OTX2(+) colonies were observed on day 13 (Figs. 4H and 4I). Together, these data revealed that the successful branch of SSC reprogramming followed the typical features of reversed developmental trajectory during embryonic development, i.e., spermatogonia to PGCs and further to the epiblasts.

The intermediate stages and key regulators during SSC reprogramming

Since RPG1/2/3/4 were identified as the pluripotent intermediated stages during SSC reprogramming, DEGs were analyzed for key regulators in these four clusters. Transcription factors (Rhox5, Prdm14, Nr0b1, and Otx2) and pluripotency-related genes (L1td1, Utf1, Nanog, and Dppa3) were significantly enriched in RPG1/2/3/4 cells (Fig. 5A; Table S6). Furthermore, transcription factor (TF) activity assessed by single-cell regulatory network inference and clustering (SCENIC) (Aibar et al., 2017; Van de Sande et al., 2020), identified regulons related to ‘stem cell proliferation and maintenance’, ‘reproductive structure development’ and ‘epithelial to mesenchymal transition’ in RPG1 to RPG4, which was in line with the features of in vivo germ cell development (Figs. 5B and S5A). Of note, Rhox5, an essential TF for PGC differentiation (Neri et al., 2013), initiated its expression in RPG1; Otx2 had been identified as a roadblock to limit entry of epiblast cells to the PGC in a precise temporal window (Zhang et al., 2018). Furthermore, Rhox5 related genes, and target genes of Prdm14 as well as Otx2 were also activated in RPG1, RPG2, and RPG3/4, respectively (Fig. 5A and 5C; Table S6).

To examine the functions of the Rhox5, Prdm14, and Otx2 in SSC reprogramming, the CasRx system was used to knockdown these genes in SSCs followed by reprogramming (Fig. 5D, Table S4) (Konermann et al., 2018). Since the expression of Rhox5, Prdm14, and Otx2 was extremely low in mouse SSCs, the CasRx based gene knockdown was first validated in gPSCs on transcription and translation levels (Fig. S5B and S5C). Two independent knockdown SSC lines (nearly 50%–80% knockdown efficiency) targeting Rhox5, Prdm14, or Otx2 were established respectively without affecting their proliferation and SSC characteristics (Fig. S5D–G). However, after reprogramming the numbers of OG(+) colonies were all dramatically decreased in Rhox5, Prdm14, or Otx2 knockdown groups, compared to the non-targeting control (Figs. 5E and S5H), moreover, the PRDM14+, TFAP2C+, DPPA3+ and OTX2+ signals were significantly decreased in OG(+) colonies derived from Rhox5-knockdown SSCs, compared to control SSCs (Figs. 5F and S5I). These data indicated critical roles for Rhox5, Prdm14, and Otx2 in SSC reprogramming.

Global DNA demethylation and erasure of methylation of imprinting genes in the early stage of SSC reprogramming

It is known that DNA methylation reprogramming is a representative and essential event in germline development (Wang et al., 2014). To explore DNA methylation dynamics, 57 cells treated by DMSO or 5C were selected for single-cell whole-genome bisulfite sequencing (scWGBS) by scTrio-seq2 (single-cell triple omics sequencing 2) to determine the DNA methylation dynamics during SSC reprogramming (Figs. 6A, S4C, and S6A–C; Table S1) (Bian et al., 2018). Integrative analysis showed a correlation between promoter DNA methylation and gene expression in SSC reprogramming, particularly for genes related to the activation of pluripotency as well as PGC-related genes (Oct4, Dppa3, Nanog, Prdm14, Zscan10, Gdf3, and Fbxo15) and repression of spermatogenesis-related genes (Dazl, Rhox13, Tm9sf5, Trim52, Sohlh2, and Rpl10l) in RPG2/3/4 (Figs. 6B, S6D and S6E; Table S7).

Hierarchical clustering and multidimensional scaling were performed, and our data were integrated with the DNA methylome profiles of E6.5 epiblast cells, in vivo germ cells from E9.5 to E16.5, and sperm (Seisenberger et al., 2012; Wang et al., 2014). From the perspective of the DNA methylome, RPG2 and RPG3 were categorized as comparable to PGCs; while RPG4, SSCs and sperm were clustered into a subgroup by multidimensional scaling (MDS) (Figs. 6C, S6F and S6G). Importantly, the level of global DNA methylation first declined from SSCs to RPG2/3, and was then elevated in RPG4, which was comparable to the in vivo germ cell DNA methylation dynamics that occurs between PGC E9.5 and E16.5 stages (Fig. 6D). Genomic features, including promoters, retrotransposons, and intragenic regions, were all demethylated in RPG2/3 and methylated in RPG4 (Figs. 6E, S6C and S6H). This indicated that genomic DNA was globally demethylated and then re-methylated during the RPG1/2/3/4 stages, and a feature of the 5C-RPGs was the enhanced demethylation that more closely matches the in vivo PGC development (Figs. 6D, 6E, and S6H). Importantly, we noticed that both paternal and maternal ICRs were also demethylated in RPG2/3, compared to SSCs and RPG1 (Figs. 6F, 6G, and S6I), which mirrored the imprinting erasure seen during in vivo PGC development. The global and imprinting demethylation as well as the expression of “chromosome organization”, “pluripotent network”, and “histone modification” related genes of RPG2/3 were more robust in the 5C group than in the control cells, suggesting the importance of thoroughly DNA demethylation and its underlying regulatory mechanisms in the early stage for SSC reprogramming (Figs. 6D–H and S6H, S6I, Table S8).

Global methylation and de novo establishment of imprinting in the late stage of SSC reprogramming

Though RPG2/3/4 were enriched with pluripotent characteristics in the early stage of SSC reprogramming, early-passage gPSCs were more similar to RPG2/3 than to RPG4, according to transcriptome- and DNA methylome features, suggesting that RPG2/3 were more likely to be the initial cells for the late stage of reprogramming (Fig. S7A and S7B). To reveal the DNA methylation dynamics during late stage of SSC reprogramming, SSCs, early- and late-passages gPSCs/5C-gPSCs, and ESCs cell were collected to perform bulk PBAT bisulfite sequencing. Global DNA methylome clustering showed that late-passage 5C-gPSCs were more similar to ESCs compared to gPSCs and early-passage 5C-gPSCs (Figs. 7A, S7C and S7D). Interestingly, we also observed that the global methylation level of 5C-gPSCs significantly increased from early-passage to late-passage during prolonged culture, reaching levels equal to ESCs; however, gPSCs did not acquire this methylation level resembling ESCs even at 25 passages (Figs. 7B, S3F and S7E). Furthermore, de novo DNA methyltransferase DNMT3B, DNA methyltransferase DNMT1 and its cofactor UHRF1 also markedly increased their expression in 5C-gPSCs than in gPSCs during prolonged cultivation (Fig. 7C), setting the stage for DNA methylation establishment during the late stage of SSC reprogramming. This indicates that the DNA methylation superiority in 5C-gPSCs over gPSCs persists even in prolonged culture (Figs. 7A–C, S3F, and S7D–E).

Next, DNA methylation dynamics of parental ICRs were carefully investigated. Indeed, in gPSCs the methylation of most maternal ICRs (including Igf2r, Snrpn, Impact, Peg3, Peg10, and Plagl1) declined and remained low in prolonged culture, whilst imprinting methylation at the same ICRs was elevated in 5C-gPSCs, giving the 5C-gPSCs a more ESC-like maternal imprinting pattern than gPSCs (Fig. 7D and 7E). As for paternal ICRs, both gPSCs and 5C-gPSCs maintained nearly 50% DNA methylation levels during the prolonged cultivation (Figs. 7D and S7F). Moreover, when we examined ICRs using individual bisulfite-converted reads, CpG sites in 5C-gPSCs and gPSCs were either near fully methylated or unmethylated in a read-dependent manner (such as Peg3 and H19), indicating the conversion of both maternal and paternal ICRs from the biallelic unmethylation in SSCs to ESC-like monoallelic methylation status in 5C-gPSCs and gPSCs (Fig. S7G). Impressively, allele split further verified the re-methylation of maternal ICRs (Impact, Peg10, and Snrpn) of one of the two alleles in one cell during the late stage of reprogramming, showing the de novo establishment of imprinting status in SSC reprogramming (Fig. 7F and 7G).

The poor developmental potential of CiPSCs inspired us to examine their DNA methylome and imprinting status (Fig. S7H; Table 1). Compared to ESCs, early passage CiPSCs (p5) were globally hypomethylated on distinct genomic features, including both paternal and maternal ICRs, suggesting extreme methylation erasure or incomplete epigenetic reprogramming in CiPSCs (p5) (Figs. 7H, 7I and S7E). These demethylation features of paternal ICRs (including H19, Rasgrf1, and IG) and maternal ICRs (including Igf2r, Gnas1a, Peg1/Mest, Gnas, Peg3, Snrpn, Peg10, and Peg13) were observed in three CiPSC lines (Fig. S7I). Moreover, DD regions and the included miRNAs encoded locus in two CiPSC lines (R-1 and K-2, p5) remained de-methylated even with long-term expansion in 2iL (p25), which provided hints for the correlation between aberrant DNA methylation loss of the whole genome or imprinting locus and the defective pluripotency of CiPSCs (Fig. S7J and S7K), which was similar to that of gPSCs, emphasizing the pivotal role of precise epigenetic reprogramming during cell fate transitions, and their biological functions.

Together, SSCs were first globally DNA demethylated and then re-methylated to an ESC-like pattern during spontaneous reprogramming with 5C induction, especially at imprinted genes acquiring mono-allelic methylation. That is, in an individual 5C-gPSC, for the ICRs of imprinting genes, one allele was fully methylated whereas the other allele was completely unmethylated. This effect was attained in a reversed germline differentiation trajectory and correlated with the true pluripotency of 5C-gPSCs (Fig. 7J).

Discussion

In mammals, germ cells carry the genetic inheritance of each individual and the epigenetic information required to produce the next generation. The cell fate reprogramming of germ cells is a fascinating question in reproductive and developmental biology. Previous studies have reported that SSCs have the potential to spontaneously reprogram to pluripotent stem cells (Kanatsu-Shinohara et al., 2004; Guan et al., 2006); however, the underlying mechanisms are largely unknown. In this study, using single-cell transcriptome and DNA methylome sequencing we provide a high-resolution landscape that uncovers the unique reprogramming trajectory and regulatory networks in SSC reprogramming.

Building on this data, we developed a five-chemical combination that targeted metabolic and epigenetic regulatory pathways to improve reprogramming efficiency about 80–100 times, which was more effective than previous reported genetic manipulation by gene overexpression (Oct4), gene knockdown (Dnmt1, Dmrt1, Trp53, or Zeb1) or signaling pathway inhibition (TGF-b) (Takashima et al., 2013; An et al., 2017). This supported our purpose to control the epigenetic remodeling and metabolic regulation that is critical for SSC reprogramming, which has not been explored in any previous attempts to improve SSC reprogramming efficiency. Moreover, we defined a large proportion of SSCs with fibroblast, meiosis, early-pluripotency, and neural features as the failed branches which helps explain the low efficiency of SSC reprogramming.

gPSCs and gPSCs derived from chemical induction in our study can both produce mice by tetraploid complementation but had not achieved in gPSCs established by Kanatsu-Shinohara et al. We speculated that some probabilities led to this capability: (1) The gPSCs developed by Kanatsu-Shinohara et al. were tetraploid complementation competent, but the number of embryos reconstructed by gPSCs may not be enough, as viable 4N-mice from ESCs was not reported in that study (Kanatsu-Shinohara et al., 2004); (2) SSC reprogramming in our study occurred after long term cultivation without splitting, rather than regular SSC cultivation protocol as Kanatsu-Shinohara et al. used, suggesting the importance of unique reprogramming trajectory and regulatory network underlying the present reprogramming environment. Most importantly, the low efficiency to obtain 4N-comp mouse from gPSCs and severe mortality of gPSC 4N-comp mouse suggested the incomplete reprogramming of gPSCs from SSCs. Whereas, the significant differences between 5C-gPSCs and gPSCs to producing 4N-comp mice also highlights the fully reprogramming of 5C-gPSCs as well as the critical role of 5C induction in SSC reprogramming.

Interestingly, compared with the primitive streak-like intermediates and two-cell like (2C-like) cells during OSKM-iPSCs and CiPSCs, respectively (Takahashi et al., 2014; Zhao et al., 2018), we identified spermatogonia-, PGC-, and epiblast-like cells as key intermediate stages during SSC reprogramming, this contrasts with the appearance of other intermediate cells in somatic cell reprogramming. Here, we show that gPSCs progress backwards through the normal developmental pathway, rather than adopting a novel cell type conversion program, for example, only 2C-like cells but not a developmental route appear in chemical reprogramming. Indeed, Rhox5 has been shown to be modulated by DNMT3L in PGC development (Neri et al., 2013), coincidentally, we show that Rhox5 is also functionally required in SSC reprogramming. This strongly supports a ‘reversed trajectory’ for the reprogramming of SSCs to gPSCs, exactly mirrored the normal in vivo developmental trajectory, as they pass through the same intermediate stages and even have the same molecular requirements, but in the reversed order. This contrasts with normal somatic reprogramming, where many reprogramming factors are essential for reprogramming, but are dispensable in differentiation (Zhuang et al., 2018).

DNA methylation signatures at imprinted genes are only removed with the switch from monoallelic methylation in the inner cell mass (ICM) and E6.5 epiblasts to hypomethylation in E13.5 PGCs. This allows the removal of the parental epigenetic ‘memory’ and subsequent imprinting re-establishment in spermatogonia and immature oocytes, which establish biallelic methylation of both alleles at most ICRs (Seisenberger et al., 2012; Gu et al., 2019). Along with the erasure and acquisition of global methylation during the early and late stage of SSC reprogramming, respectively, imprinted locus in SSCs were symmetrically methylated on both alleles and converted to an asymmetric re-methylated status on one of the two alleles in 5C-gPSCs. This newly identified imprinting re-methylation of one of the two alleles in the late stage of SSC reprogramming has not been previously observed in any in vivo developmental processes or in vitro reprogramming, as DNA re-methylation on both alleles in spermatogonia and immature oocytes, and imprinting maintenance in somatic cell differentiation as well as reprogramming (Reik et al., 2001). Moreover, it was interesting as 5C treatment was only applied to SSCs undergoing reprogramming in the early stage (Fig. 2C; days 0 to 19), yet implying the indirectly impact of the 5C combination even in the late stage of reprogramming (Fig. 7D and 7E). This provides a new angle to understand as well as a novel strategy to manipulate reprogramming of imprinting genes (Fig. 7J).

Previous studies have shown that genomic imprinting plays a pivotal role in the growth, viability, and various physiological functions of mammalian embryos (Tucci et al., 2019). We showed that imprinting defects were much less in 5C-gPSCs than gPSCs, and provided an explanation for the reduced developmental and growth disorders observed in embryos and pups derived from 5C-gPSCs than gPSCs. Accordingly, CiPSCs had limited developmental potential and global imprinting loss. Due to the importance of correct imprinting in PSCs, it was important to further dissect the underlying regulatory mechanisms behind de novo establishment of imprinting status during SSC reprogramming. Potentially, this may bring insights into the mechanisms beyond accurate imprinting erasure and re-establishment, which remains somewhat unclear. Additionally, fine-tuned control of imprinting may help overcoming epigenetic disorders to improve other cell fate decisions, and rescue imprinting aberrations from uniparental disomy. Indeed, in addition to the epigenetic disorders of CiPSCs, recent studies have revealed that the mutation rate in somatic cells is much higher than that originated from germline cells (Moore et al., 2021; Yang et al., 2021), suggesting that SSC reprogramming would be a safer strategy to obtain pluripotent stem cells with less mutations than somatic cells reprogramming.

Overall, we systematically dissect SSC reprogramming at single cell resolution, and based on the rational application of chemicals we can drastically improve the efficiency up to 80- to 100-folds, and in the process our approach also repairs the poor developmental potential of gPSCs. The conversion of SSCs to pluripotent stem cells is accompanied by epigenetic reprogramming which mirrored in vivo germ cell development. Finally, this unique trajectory and regulatory network of SSC reprogramming described here expands our understanding of cell fate reprogramming, such knowledge paves the way to obtain high-quality iPSCs without genetic manipulation for future clinical applications in regenerative medicine.

Materials and methods

Animal model and ethics statement

C57BL/6 and KM mice were from the laboratory animal center of Southern Medical University, Oct4-EGFP and CAG-EGFP transgenic C57BL/6 mice and DBA/2 mice were purchased from Nanjing Biomedical Research Institute of Nanjing University. Oct4-EGFP transgenic mice express Enhanced Green Fluorescent Protein (EGFP) under the control of the POU protein domain, class 5, transcription factor 1, promoter and distal enhancer. ICR mice were purchased from Guangdong Medical Laboratory Animal Center.

Establishment of gPSCs, CiPSCs, and cell culture of PSCs

B6D2F1 SSCs were derived from the 5.5 days postpartum (dpp) male mice generated by mating Oct4-EGFP or EGFP transgenic C57BL/6 female with DBA/2 male. SSCs derivation and expansion were performed according to the previously study (Wang et al., 2021), with culture medium containing 20 ng/mL mouse epidermal growth factor (EGF) (R&D), 10 ng/mL human basic fibroblast growth factor (bFGF) (R&D), 10 ng/mL rat glial cell line-derived neurotrophic factor (R&D) and 103 U/mL ESGRO (Sigma-Aldrich). gPSCs were established by following Ko et al.’s protocol (Ko et al., 2009), briefly, approximately 4,000 single cells of SSCs were plated on one well of 6 µg/mL fibronectin (Millipore) coated 24-well plate containing mitomycin C-inactivated mouse embryonic fibroblast (MEF) feeder cells in SSC culture medium, the medium was changed every 3 days. OG(+) colonies could be observed within 2 to 4 weeks.

R-1 CiPSCs were established from MEF of Oct4-EGFP transgenic mice (C57BL/6 background) as previous study (Zhao et al., 2015). K-2 CiPSCs (C57BL/6 background) were gifted from Liu lab (Cao et al., 2018). D-1 CiPSCs were reprogrammed from MEF of Oct4-EGFP transgenic mice (B6D2F1 background) with an efficient protocol (Zhao et al., 2018). ESCs were established from Oct4-EGFP blastocysts (B6D2F1 background) according to previous protocol (Ying et al., 2008). gPSCs, 5C-gPSCs, ESCs, and CiPSCs were maintained on feeder layers in ground state ESC culture medium N2B27 supplemented with 2iL (3 µmol/L CHIR99021, 1 µmol/L PD0325901, and 103 U/mL ESGRO). SSCs and PSCs were maintained at 37°C in an atmosphere of 5% CO2 in air.

Isolation and collection of SSCs, reprogramming cells and gPSCs for single-cell profiling

Four thousand two hundred forty-seven and 1,089 single cells during SSC reprogramming and SSCs as well as PSCs were collected for scRNA-seq and scTrio-seq2, separately. SSC- and PSC-like colonies were selected and digested in 0.05% trypsin for 3 min, followed by inactivation of trypsin by DMEM (ThermoFisher) (containing 10% FBS). After centrifugation, these cells were suspended in DMEM (containing 10% FBS) for further sample selection by using a mouth pipette to transfer single cells into prepared lysis buffer with an 8-nt barcode.

scRNA-seq library preparation and sequencing

The preparation of single cell RNA-seq library was performed using the modified single-cell tagged reverse transcription sequencing (STRT-seq) protocol (Dong et al., 2018). Briefly, the single cell was lysed and add 2.85 μL reverse transcription (RT) mix containing 500 U SuperScript II reverse transcriptase (Invitrogen), 4 U RNase inhibitor (TAKARA), 30 mmol/L MgCl2, and 5 µmol/L TSO primer, followed by incubation at 25°C for 5 min, 42°C for 60 min, 50°C for 30 min and 70°C for 10 min. Then the cDNA amplification and purification by 0.8× AMPure XP beads (Beckman) was performed. Biotin PCR was further carried out and enriched. Finally, the single cell RNA-seq library was prepared according to the Hyper Prep Kits with PCR Library Amplication/Illumina series (KAPA). The libraries were checked and sequenced with 150 bp pair-end reads on Illumina Hiseq 4000 (Novogene).

Processing of scRNA-seq data

We firstly extracted cell barcodes and UMI sequences from read 2 of raw fastq data by UMItools (v1.0.0) (Smith et al., 2017) and attached them after the read name of read 1. After TSO and polyA sequence removal by local scripts, the ‘clean’ reads were aligned to the mouse mm10 reference genome using STAR (2.7.2b) (Dobin et al., 2013), gene features were assigned by featureCounts (v2.0.0) (Liao et al., 2014). We used UMItools to generate UMI count expression matrix.

For the quality control of scRNA-seq data, cells with detected gene numbers fewer than 2,000 or the fraction of mitochondrial reads more than 5% were excluded from further analysis, additionally, genes expressed in less than 3 cells were filtered out of the analysis.

Dimensional reduction and cell clustering

Seurat (v3.1.3) (Butler et al., 2018; Stuart et al., 2019) was used for principal component analysis (PCA) and UMAP dimensional reduction of scRNA-seq data. Cell clusters were detected by shared nearest neighbor (SNN) modularity optimization-based clustering algorithm using Seurat function ‘FindClusters’ with default parameters. Cell types were assigned based on the expression of canonical marker genes and the differential expressed genes (DEGs) of each cluster. For scRNA-seq of 5C and DMSO-induced SSC reprogramming, cell types identification by scPred with a machine-learning probability-based prediction method (Alquicira-Hernandez et al., 2019). In detailed, scRNA-seq data of SSC reprogramming from control system were used to build reference object and train cell-type classifier with default parameters. The query data of 5C and DMSO scRNA-seq were then aligned to reference and classified with the ‘scPredict’ function, respectively. The prediction processes were repeated 500 times with different random seeds for each dataset, and the cell-type predicted the most times for each cell was assigned as cell type labels.

Single-cell trajectory analysis

We used three different algorithms to infer the trajectory of SSC reprogramming, including PAGA (partition-based graph abstraction) (Wolf et al., 2019), RNA velocity (La Manno et al., 2018), and Monocle2 (Trapnell et al., 2014). PAGA was performed in SCANPY (1.4.4) (Wolf et al., 2018) by converting Seurat object into a loom format. SNN graph and UMAP embedding calculated in Seurat were used to map the coarse-grained structures. For RNA velocity, command line interface of velocyto.py was used to generate spliced and un-spliced expression matrices from aligned bam files, and then the RNA velocity of each cell were estimated by velocity.R and visualized in UMAP plot. Monocle2 trajectories were constructed according the default workflow, top 2,000 highly variable genes identified from Seurat procedure were used to construct the trajectory of all clusters in the early stage of SSC reprogramming related to Fig. S2B. Top 100 DEGs of each cluster were used to construct trajectory of successful reprogramming branch (including SSC1-4 and RPG 1-4) related to Fig. 1G.

Identification of differentially expressed genes and GO analysis

Differential expressed genes (DEGs) of all clusters were found by Seurat ‘FindAllMarkers’ function with parameter ‘logfc.threshold = 0.5’. Only DEGs with adjusted P-value < 0.05 were remained. DEGs among clusters were found by Seurat ‘FindMarkers’ functions with the same criterion. Gene ontology (GO) enrichment analysis was performed using Metascape (Zhou et al., 2019).

Gene signatures

For better identify and describe the characteristic of cells, we constructed gene sets and scored cells based on their expression of these genes, as previous described by Schiebinger et al. (2019). In detail, the signature used in Fig. S2D was constructed from top 100 upregulated DEGs of SSCs (SSC signature), ESCs (pluripotency signature) and other corresponding clusters. In Fig. S2H, ‘Glycolysis/Gluconeogenesis’ signature was derived from KEGG pathway mmu00010, ‘DNA transmethylase & demethylase’ signature included Dnmt1, Dnmt3a, Dnmt3b, Dnmt3l, Tet1, Tet2, Tet3, and Tdg. The pluripotency signature was defined by the expression of a set of canonical pluripotency genes (Table S2).

Transcriptional comparison between SSC reprogramming and fibroblast reprogramming (CiPSC and OSKM-iPSC)

RPG1 of SSC reprogramming (this study), cells at day 10 of stage III during CiPSC induction (Zhao et al., 2018), and cells at day 6 of OSKM-iPSC reprogramming (Schiebinger et al., 2019) initiating their expression of pluripotent-related genes were designated as key intermediate states in each reprogramming process. Stages 1 and 2 of each reprogramming process were divided by the above-mentioned intermediate states. DEGs and GO term analysis were performed and compared among these three distinct reprogramming processes in stages 1 and 2, respectively.

Immunofluorescence and alkaline phosphatase staining

For immunofluorescence staining, the cells were cultured on coverslips and fixed with 4% paraformaldehyde for 30 min and then permeated with 0.3% Triton X-100 for 15 min followed by blocking with 5% BSA (Sigma-Aldrich) at room temperature. Afterwards, cells were incubated with primary antibodies at 4°C overnight and secondary antibody at room temperature for 1 h. The nuclei were counterstained with 10 μg/mL Hoechst 33342 (Thermofisher) for 15 min at room temperature. Images were captured by confocal microscope (ZEISS LSM880). Alkaline phosphatase staining was performed with BCIP/NBT Alkaline Phosphatase Color Development Kit (Beyotime) according to manufacturer’s instructions. Images were captured with stereomicroscope (Zeiss, Axio Zoom. V16).

The primary antibodies used in this study were listed: Goat anti-GFRa1 (R&D, AF714), Mouse anti-ZBTB16 (Santa, sc-28319), Rabbit anti-DDX4 (Abcam, ab13840), Mouse anti-POU5F1 (OCT4) (Abcam, ab19857), Mouse anti-POU5F1 (OCT4) (Santa, sc-5279), Mouse anti-SSEA1(Sigma-Aldrich, MAB4301), Rabbit anti-NANOG (Abcam, ab70482), Rabbit anti-RHOX5 (Abcam, ab31922), Rabbit anti-PRDM14 (Cell Signaling Technology, 83527), Goat anti-OTX2 (R&D, AF1979), Rabbit anti-DPPA3 (Abcam, ab19878), Rabbit anti-L1TD1(Biorbyt, orb35537), Mouse anti-TFAP2C (Santa, sc-12762), Rabbit anti-DNMT3B (proteintech, 26971-1-AP), Rabbit anti-DNMT1 (abclonal, A16729), Mouse anti-UHRF1 (Santa, sc-373750), and Mouse anti-ACTIN (proteintech, CL594-66009). The secondary antibodies (Jackson ImmunoResearch) used in this study: Goat Alexa Fluor 594 anti-rabbit IgG (111-585-003), Goat Alexa Fluor 488 anti-rabbit IgG (111-545-003), Goat Alexa Fluor 647 anti-mouse IgG (115-605-003), Goat Alexa Fluor 594 anti-mouse IgG (115-585-003), Goat Alexa Fluor 594 anti-goat IgG (705-585-003), and Donkey Cy2 anti-goat IgG (705-225-147). Enhanced chemiluminescence peroxidase-labeled anti-mouse or rabbit antibodies (ZSGB-BIO, ZB-2305 or ZB-2301) were used for western blotting analysis. The intense analysis was performed by ImageJ (National Institutes of Health).

Teratoma formation

Teratoma formation was performed as previously described (Zhao et al., 2009). In brief, 1 × 106 cells of gPSCs (gPSC-1 p10) and 5C-gPSCs (5C-gPSC-1 p10) were suspended at 100 µL PBS, respectively. These cells were subcutaneously injected into the inguen of 8-week-old male NSG mice. Six to 8 weeks later, injected mice were sacrificed and teratomas were fixed with 4% paraformaldehyde. Paraffin sections were stained with hematoxylin and eosin.

Extracellular lactic acid analysis and 2-DG treatment

Extracellular lactate content was measured by the Lactate Assay Kit (Sigma-Aldrich). Standard curves were plotted as manufacturer’s instruction. Supernatants without insoluble material during SSC reprogramming were collected for subsequent reaction with Lactate Enzyme mix and Lactate Substrate Mix at room temperature avoid from light for 30 min. Absorbances at 450 nm (A450) of each sample were measured by an automated micro plate reader (TECAN®infinite M200). SSCs were treated with 2-DG (Target Mol) during reprogramming, and the concentration of 2-DG was applied as previously described (Kanatsu-Shinohara et al., 2016).

Chemical screening

Epigenetics Compound library (Target Mol) and some in-house chemical collections were applied for the chemical screening (Table S4), each individual compound at 10 µmol/L concentration was added into each well with three repeats for the first-round screening. From 10 days after treatment, the number of OG(+) colonies was counted under a fluorescence microscope to evaluate the reprogramming efficiency of each chemical. After the first-round screening, concentration test and compound combination were further performed for a high-efficient combination.

Diploid blastocyst injection and tetraploid embryo complementation

The generation of mice by diploid blastocyst injection and tetraploid embryo complementation was carried out as previously described (Zhao et al., 2009). For diploid blastocyst injection, 10 to 15 pluripotent stem cells (B6D2F1 genetic background, black coat color) were injected into each diploid blastocyst collected from ICR female mice. For tetraploid embryo complementation, two-cell stage embryos were collected from oviducts of ICR females (white coat color) and electrofused by Electro Cell Manipulator (BTX, EMC2001) to produce one-cell tetraploid embryos that were then cultured in M2 medium (Sigma-Aldrich). Eight pluripotent stem cells were injected into each tetraploid blastocyst. Every 16 injected blastocysts were transplanted into one ICR pseudopregnant recipient female. Embryos derived from diploid- and tetraploid-blastocyst injection were dissected on E12.5 and the day of birth (E19.5), respectively. Fluorescence and bright field images of chimeric embryos were captured by stereomicroscope (Zeiss, Axio Zoom.V16).

Determination of the SSLP by PCR

The SSLP determination was performed as previously described (Zhou et al., 2001). Sequences for the primer pairs were found on the Mouse Genome Informatics website. DNA was extracted from mouse tail tips with DNA Isolation Mini Kit (Vazyme). PCR Products were separated by 3% agarose gels and visualized by ethidium bromide staining. Primers were listed in Table S4.

Integrative and comparative analysis of scRNA-seq data of SSC reprogramming and in vivo germ cell development

In order to compare the transcriptional signature of SSC reprogramming process and in vivo mouse germ cell development, the Harmony (v1.0) algorithm (Korsunsky et al., 2019) was used to integrate these two datasets through Seurat function ‘RunHarmony’ with default parameters. scmap (v1.1.6) (Kiselev et al., 2018) was used to perform cell types projection between datasets of the successful branch of SSC reprogramming and in vivo germ cell development.

Derivation of transgenic SSC lines

Gene knockdown was performed by using CRISPR/CasRx system for targeting Rhox5, Prdm14, and Otx2. Lentivirus packaging and transfection were performed as previously described (Konermann et al., 2018; Wessels et al., 2020). Stably transfected SSCs were purified by the addition of puromycin (Thermofisher) and zeocin (Thermofisher) at a final concentration of 0.4 and 15 μg/mL for about 1 week, respectively. gRNA sequences were listed in Table S4.

Quantitative PCR (q-PCR) analysis

PSCs were lysed in Trizol reagent (TIANGEN), and total RNA was isolated using Chloroform extraction and treated with DNase. cDNA was synthesized using HiScript® II Reverse Transcriptase (Vazyme). q-PCR was performed using 2× RealStar Green Fast Mixture (GenStar) on LightCycle® Real-Time PCR System (Roche). The data were analyzed using the delta-delta Ct method. Geometric mean of Rps2 and Gapdh was used as an inner control to normalize the expression of target genes. Primers were listed in Table S4.

Transcription factor analysis

We performed pySCENIC (single-cell regulatory network inference and clustering) (Aibar et al., 2017; Van de Sande et al., 2020) analysis to identify activated TFs and regulatory sub-network of each TF (regulons) for successful branch of SSC reprogramming. For TFs not included in SCENIC’s TFs list, we identified TFs according to TFs list from TcoF-DB (Schmeier et al., 2017) and constructed regulons based on PPI information of STRING database as supplementation. TF-targets network constructed from SCENIC were visualized by Cytoscape (v3.9.1) (Shannon et al., 2003).

Single-cell Trio-seq2 sequencing

scTrio-seq library was constructed following previously reported modified scTrio-seq2 protocol (Bian et al., 2018). In details, each single cell was picked into lysis buffer containing magnetic beads (Invitrogen). Single cells were lysed and vortexed for 1 min to release RNA, and placed on the magnetic rack for 5 min. Supernatants containing RNA were transferred to a new tube for scRNA-seq, nuclei aggregated with magnetic beads were maintained in the pellet and re-suspended with lysis buffer of scBS-seq for DNA methylation sequencing. Bisulfite conversion was conducted by EZ-96 DNA Methylation-Direct MagPrep kit (Zymo). Four rounds of amplification were performed with Klenow exo- (ENzymics) and scBS-seq-P5-N6-oligo1 (CTACACGACGCTCTTCCGATCTNN-NNNN). After purification by 0.8× AMPure XP beads, the products were used to synthesize the second strand using scBS-seq-P7-N6-oligo2 (AGACGTGTGCTCTTCCGATCTNNNNN). 16 cycles of PCR program were subsequently performed to complete the DNA library construction incorporated with universal primers and index primers (New England Biolabs), followed by twice purification with 0.8× AMPure XP beads. DNA libraries were sequenced on the Illumina Nova platform with 150 bp paired-end reads.

Post-bisulfite adaptor tagging (PBAT) library preparation

PBAT was performed as the published protocols (Smallwood et al., 2014). Briefly, genomic DNA was extracted using FastPure Cell/Tissue DNA Isolation Mini Kit (Vazyme, DC102). Then 5 ng isolated genomic DNA together with 60 pg unmethylated lambda DNA (ThermoFisher) were subjected to bisulfite conversion, followed by column-based purification (Zymo, D4014). Next, random priming, library amplification and subsequent sequencing were conducted on the bisulfite-converted DNA for single-cell DNA methylation library preparation described above.

Bisulfite sequence data process

Trim_galore (v0.6.4) was used to remove low quality reads and adaptor sequence, and 9 bp random primers from 5ʹ end of both read 1 and read 2 were also trimmed. Clean reads were then mapped to mm10 genome using Bismark (v0.23.0) with paired-end mode and ‘--non_directional’ option. Unmapped reads were outputted and mapped again by single-end mode. Aligned bam files were merged and sorted by samtools (v 1.11) and PCR duplicates were marked and removed by picard MarkDuplicates (v2.23.6). Methylation calls for each CpG site were extracted by ‘bismark_methylation_extractor’ of Bismark. The thresholds for CpG sites coverage were 1× and 3× for single-cell and bulk DNA methylome, respectively. Only methylation levels less than 10% or greater than 90% were retained for single-cell methylation data. Bisulfite conversion rate (BSCR) was estimated by methylation ratio of lambda DNA, samples with BSCR greater than 98% and detected CpG sites greater than 1,000,000 were kept for further analysis. BedGraph files containing methylated and unmethylated sites were generated by local scripts and converted to bigwig format by UCSC binary tools ‘bedGraphToBigWig’ (v4).

Methylation levels of genomic elements and differentially methylated promoters

The annotation of known genomic elements was downloaded from UCSC genome browser, including RefSeq genes, CGI, enhancers and so on. The annotations of transposable elements were obtained from RepeatMasker of UCSC table browser. Promoters were defined as the 2-kb upstream and downstream of transcription start sites (TSS) according to RefSeq gene annotation. The methylation level of each genomic element was calculated by the average methylation level of all covered CpG sites (at least 3 CpG sites). The global methylation level of each sample was measured by the average methylation level of all the genomic 1-kb windows (at least 3 CpG sites). The scaled methylation levels of RefSeq genebodies and CGIs (CpG islands) were calculated by the ‘computeMatrix’ command of deeptools (v3.4.3) in scale-region mode and visualized by local scripts. Differentially methylated promoters (DMPs) with methylation difference greater than 30% and P value <0.05 were found in every two clusters by multiple t-test.

Clustering of global methylation

To compare the global methylation level of distinct samples, the average methylation levels of all 1-kb tiles covered by more than 80% samples were applied to calculate Euclidean distance among samples by ‘dist’ function of R ‘stats’ package. Distance matrix was used to perform hierarchical clustering by ‘hclust’ function. We also performed multidimensional scaling (MDS) analysis with the Euclidean distance and projected it in two-dimensional space.

Correlation analysis between gene expression and promoter DNA methylation

To calculate the correlation between gene expression and DNA methylation during SSC reprogramming, average gene expression levels and promoter DNA methylation levels derived from Trio-seq2 data were calculated for each gene in each cluster of successful branch, respectively. Pearson correlation coefficient was then determined by ‘cor’ function with default parameter in R.

Methylation of allele-specific imprinting control regions

Known imprinting control regions (ICRs) were annotated and the methylation level of each ICR were calculated as previously mentioned. To investigate the allele-specific methylation of ICRs, SNPsplit (v0.4.0) (Krueger and Andrews, 2016) was used to determine the allelic origin of distinct reads via known SNP positions. In detail, SNP information for C57BL/6NJ and DBA/2J (dbSNP142) were downloaded from MGP websites. Dual strain reference genome was generated according to SNPsplit workflow and the strain-specific SNP positions were masked by Ns. Bisulfite alignment was performed by Bismark again and allele-specific alignments were split, the methylation information of each allele was extracted separately. The methylation calls by reads which covering ICRs were extracted from Bismark’s CpG context-dependent methylation files and lollipop methylation diagrams showing methylation information of each CpG site for distinct reads were generated by local script and visualized with ‘ggplot2’ package in R.

References

[1]

Aibar S, Gonzalez-Blas CB, Moerman T et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods 2017;14:1083–+.

[2]

Alquicira-Hernandez J, Sathe A, Ji HP et al. scPred: accurate supervised method for cell-type classification from single-cell RNA-seq data. Genome Biol 2019;20:264.

[3]

An J, Zheng Y, Dann CT. Mesenchymal to epithelial transition mediated by CDH1 promotes spontaneous reprogramming of male germline stem cells to pluripotency. Stem Cell Rep 2017;8:446–459.

[4]

Bian S, Hou Y, Zhou X et al. Single-cell multiomics sequencing and analyses of human colorectal cancer. Science 2018;362:1060–1063.

[5]

Butler A, Hoffman P, Smibert P et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 2018;36:411–+.

[6]

Byrne JA, Pedersen DA, Clepper LL et al. Producing primate embryonic stem cells by somatic cell nuclear transfer. Nature 2007;450:497–502.

[7]

Cao S, Yu S, Li D et al. Chromatin accessibility dynamics during chemical induction of pluripotency. Cell Stem Cell 2018;22:529–542.e525.

[8]

Choi J, Huebner AJ, Clement K et al. Prolonged Mek1/2 suppression impairs the developmental potential of embryonic stem cells. Nature 2017;548:219–223.

[9]

Costoya JA, Hobbs RM, Barna M et al. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 2004;36:653–659.

[10]

Dobin A, Davis CA, Schlesinger F et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013;29:15–21.

[11]

Dong J, Hu Y, Fan X et al. Single-cell RNA-seq analysis unveils a prevalent epithelial/mesenchymal hybrid state during mouse organogenesis. Genome Biol 2018;19:31.

[12]

Gu C, Liu S, Wu Q et al. Integrative single-cell analysis of transcriptome, DNA methylome and chromatin accessibility in mouse oocytes. Cell Res 2019;29:110–123.

[13]

Guan K, Nayernia K, Maier LS et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006;440:1199–1203.

[14]

Gurdon JB, Byrne JA. Classic Perspective: The first half-century of nuclear transplantation. Proc Natl Acad Sci USA 2003;100:8048–8052.

[15]

Hou P, Li Y, Zhang X et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 2013;341:651–654.

[16]

Jeong HS, Bhin J, Joon Kim H et al. Transcriptional regulatory networks underlying the reprogramming of spermatogonial stem cells to multipotent stem cells. Exp Mol Med 2017;49:e315.

[17]

Kanatsu-Shinohara M, Inoue K, Lee J et al. Generation of pluripotent stem cells from neonatal mouse testis. Cell 2004;119:1001–1012.

[18]

Kanatsu-Shinohara M, Ogonuki N, Inoue K et al. Long-term proliferation in culture and germline transmission of mouse male germline stem cells. Biol Reprod 2003;69:612–616.

[19]

Kanatsu-Shinohara M, Tanaka T, Ogonuki N et al. Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal. Genes Dev 2016;30:2637–2648.

[20]

Kiselev VY, Yiu A, Hemberg M. scmap: projection of single-cell RNA-seq data across data sets. Nat Methods 2018;15:359–362.

[21]

Ko K, Tapia N, Wu G et al. Induction of pluripotency in adult unipotent germline stem cells. Cell stem cell 2009;5:87–96.

[22]

Konermann S, Lotfy P, Brideau NJ et al. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors. Cell 2018;173:665–+.

[23]

Korsunsky I, Millard N, Fan J et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods 2019;16:1289–1296.

[24]

Krueger F, Andrews SR. SNPsplit: Allele-specific splitting of alignments between genomes with known SNP genotypes. F1000Res 2016;5:1479.

[25]

La Manno G, Soldatov R, Zeisel A et al. RNA velocity of single cells. Nature 2018;560:494–+.

[26]

Li R, Liang J, Ni S et al. A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 2010;7:51–63.

[27]

Li TD, Feng GH, Li YF et al. Rat embryonic stem cells produce fertile offspring through tetraploid complementation. Proc Natl Acad Sci USA 2017;114:11974–11979.

[28]

Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 2014;30:923–930.

[29]

Liu L, Luo GZ, Yang W et al. Activation of the imprinted Dlk1-Dio3 region correlates with pluripotency levels of mouse stem cells. J Biol Chem 2010;285:19483–19490.

[30]

Ly CH, Lynch GS, Ryall JG. A metabolic roadmap for somatic stem cell fate. Cell Metab 2020;31:1052–1067.

[31]

Matoba S, Wang H, Jiang L et al. Loss of H3K27me3 imprinting in somatic cell nuclear transfer embryos disrupts post-implantation development. Cell stem cell 2018;23:343–354.e345.

[32]

Moore L, Cagan A, Coorens THH et al. The mutational landscape of human somatic and germline cells. Nature 2021;597:381–386.

[33]

Neri F, Krepelova A, Incarnato D et al. Dnmt3L antagonizes DNA methylation at bivalent promoters and favors DNA methylation at gene bodies in ESCs. Cell 2013;155:121–134.

[34]

Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science 2001;293:1089–1093.

[35]

Romanienko PJ, Camerini-Otero RD. The mouse Spo11 gene is required for meiotic chromosome synapsis. Mol Cell 2000;6:975–987.

[36]

Samavarchi-Tehrani P, Golipour A, David L et al. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell stem cell 2010;7:64–77.

[37]

Schiebinger G, Shu J, Tabaka M et al. Optimal-transport analysis of single-cell gene expression identifies developmental trajectories in reprogramming. Cell 2019;176:928–943.e922.

[38]

Schmeier S, Alam T, Essack M et al. TcoF-DB v2: update of the database of human and mouse transcription co-factors and transcription factor interactions. Nucleic Acids Res 2017;45:D145–D150.

[39]

Schrans-Stassen BH, Saunders PT, Cooke HJ et al. Nature of the spermatogenic arrest in Dazl -/- mice. Biol Reprod 2001;65:771–776.

[40]

Seisenberger S, Andrews S, Krueger F et al. The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol Cell 2012;48:849–862.

[41]

Shannon P, Markiel A, Ozier O et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003;13:2498–2504.

[42]

Smallwood SA, Lee HJ, Angermueller C et al. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods 2014;11:817–820.

[43]

Smith T, Heger A, Sudbery I. UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy. Genome Res 2017;27:491–499.

[44]

Stadtfeld M, Apostolou E, Akutsu H et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 2010;465:175–181.

[45]

Stuart T, Butler A, Hoffman P et al. Comprehensive integration of single-cell data. Cell 2019;177:1888–1902.e1821.

[46]

Szabó PE, Hübner K, Schöler H et al. Allele-specific expression of imprinted genes in mouse migratory primordial germ cells. Mech Dev 2002;115:157–160.

[47]

Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861–872.

[48]

Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotency in human somatic cells via a transient state resembling primitive streak- like mesendoderm. Nat Commun 2014;5:3678.

[49]

Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663–676.

[50]

Takashima S, Hirose M, Ogonuki N et al. Regulation of pluripotency in male germline stem cells by Dmrt1. Genes Dev 2013;27:1949–1958.

[51]

Takikawa S, Ray C, Wang X et al. Genomic imprinting is variably lost during reprogramming of mouse iPS cells. Stem Cell Res 2013;11:861–873.

[52]

Tarazona OA, Pourquie O. Exploring the influence of cell metabolism on cell fate through protein post-translational modifications. Dev Cell 2020;54:282–292.

[53]

Trapnell C, Cacchiarelli D, Grimsby J et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol 2014;32:381–386.

[54]

Tucci V, Isles AR, Kelsey G et al; Erice Imprinting Group. Genomic imprinting and physiological processes in mammals. Cell 2019;176:952–965.

[55]

Van de Sande B, Flerin C, Davie K et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat Protocols 2020;15:2247–2276.

[56]

Wang L, Zhang J, Duan J et al. Programming and inheritance of parental DNA methylomes in mammals. Cell 2014;157:979–991.

[57]

Wang M, Xu YW, Zhang YC et al. Deciphering the autophagy regulatory network via single-cell transcriptome analysis reveals a requirement for autophagy homeostasis in spermatogenesis. Theranostics 2021;11:5010–5027.

[58]

Wessels HH, Mendez-Mancilla A, Guo XY et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Nat Biotechnol 2020;38:722–+.

[59]

Wolf FA, Angerer P, Theis FJ. SCANPY: large-scale single-cell gene expression data analysis. Genome Biol 2018;19:15.

[60]

Wolf FA, Hamey FK, Plass M et al. PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells. Genome Biol 2019;20:59.

[61]

Xie Y, Khan R, Wahab F et al. The testis-specifically expressed Dpep3 is not essential for male fertility in mice. Gene 2019;711:143925.

[62]

Yagi M, Kabata M, Ukai T et al. De Novo DNA methylation at imprinted loci during reprogramming into naive and primed pluripotency. Stem Cell Rep 2019;12:1113–1128.

[63]

Yagi M, Kishigami S, Tanaka A et al. Derivation of ground-state female ES cells maintaining gamete-derived DNA methylation. Nature 2017;548:224–227.

[64]

Yang XX, Breuss MW, Xu X et al. Developmental and temporal characteristics of clonal sperm mosaicism. Cell 2021;184:4772–+.

[65]

Ying QL, Wray J, Nichols J et al. The ground state of embryonic stem cell self-renewal. Nature 2008;453:519–523.

[66]

Zhang J, Zhang M, Acampora D et al. OTX2 restricts entry to the mouse germline. Nature 2018;562:595–599.

[67]

Zhang T, Oatley J, Bardwell VJ et al. DMRT1 is required for mouse spermatogonial stem cell maintenance and replenishment. PLoS Genet 2016;12:e1006293.

[68]

Zhao J, Lu P, Wan C et al. Cell-fate transition and determination analysis of mouse male germ cells throughout development. Nat Commun 2021;12:6839.

[69]

Zhao T, Fu Y, Zhu J et al. Single-cell RNA-Seq reveals dynamic early embryonic-like programs during chemical reprogramming. Cell stem cell 2018;23:31–45.e37.

[70]

Zhao XY, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86–90.

[71]

Zhao Y, Zhao T, Guan J et al. A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming. Cell 2015;163:1678–1691.

[72]

Zhou Q, Jouneau A, Brochard V et al. Developmental potential of mouse embryos reconstructed from metaphase embryonic stem cell nuclei. Biol Reprod 2001;65:412–419.

[73]

Zhou Q, Wang M, Yuan Y et al. Complete meiosis from embryonic stem cell-derived germ cells in vitro. Cell Stem Cell 2016;18:330–340.

[74]

Zhou Y, Zhou B, Pache L et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 2019;10:1523.

[75]

Zhuang Q, Li WJ, Benda C et al. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming (vol 20, pg 400, 2018). Nat Cell Biol 2018;20:1227–1227.

RIGHTS & PERMISSIONS

©The Author(s) 2022. Published by Oxford University Press on behalf of Higher Education Press.

PDF (12777KB)

Supplementary files

PAC-0477-22244-ZXY_suppl_1

PAC-0477-22244-ZXY_suppl_2

PAC-0477-22244-ZXY_suppl_3

PAC-0477-22244-ZXY_suppl_4

PAC-0477-22244-ZXY_suppl_5

PAC-0477-22244-ZXY_suppl_6

PAC-0477-22244-ZXY_suppl_7

PAC-0477-22244-ZXY_suppl_8

PAC-0477-22244-ZXY_suppl_9

972

Accesses

0

Citation

Detail

Sections
Recommended

/